Evotec Overview

  • Founded
  • 1993
Founded
  • Status
  • Public
  • Employees
  • 1,764
Employees
  • Stock Symbol
  • EVT
Stock Symbol
  • Investments
  • 38
  • Share Price
  • $27.22
  • (As of Friday Closing)

Evotec General Information

Description

Evotec SE is a drug discovery partnership company providing drug discovery solutions to pharmaceutical and biotechnology companies, academic institutions as well as foundations and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes and complications of diabetics, pain and inflammation, oncology and infectious diseases. Its business segments are EVT execute and EVT Innovate. The EVT execute provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The majority of the revenue is generated from the EVT execute segment.

Contact Information

Website
Formerly Known As
Evotec BioSystems
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
ETR
Primary Office
  • Manfred Eigen Campus
  • Essener Bogen 7
  • 22419 Hamburg
  • Germany
+49 040 000000

Evotec Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evotec Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$27.22 $27.47 $19.15 - $29.95 $4.42B 162M 727K $0.25

Evotec Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 4,268,718 4,034,746 2,904,384 2,443,117
Revenue 520,055 499,762 443,003 297,465
EBITDA 92,450 123,801 123,889 54,059
Net Income 38,328 42,620 99,329 26,475
Total Assets 1,339,119 1,322,825 882,959 799,572
Total Debt 550,944 518,751 130,937 227,857
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Evotec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Evotec‘s full profile, request access.

Request a free trial

Evotec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Evotec SE is a drug discovery partnership company providing drug discovery solutions to pharmaceutical and biotechnology
Drug Discovery
Hamburg, Germany
1,764 As of 2020
00000
0.00 0000-00-00
000000000 00000

0000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000 000000000
Cambridge, MA
00 As of 0000
00000
000000000 00000

0000000

smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
0000 000000000
Devon, PA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Evotec Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genocea Biosciences Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Devon, PA 00 00000 00000000 00000
000 00000000(00000 Corporate Backed or Acquired Cambridge, MA 000 000.00 00000000 000.00
0000000000 Venture Capital-Backed Planegg, Germany 00.000 000000 0 00.000
00000000 Corporation Basel, Switzerland 000000 000000000000
You’re viewing 5 of 25 competitors. Get the full list »

Evotec Executive Team (23)

Name Title Board Seat Contact Info
Werner Lanthaler MD Chief Executive Officer
Enno Spillner Chief Financial Officer & Board Member
Craig Johnstone Chief Operating Officer
Cord Dohrmann Ph.D Chief Scientific Officer & Board Member
Isabelle Bergere Ph.D Group Leader, Compound Management
You’re viewing 5 of 23 executive team members. Get the full list »

Evotec Board Members (11)

Name Representing Role Since
00000 000000000 Evotec Supervisory Board Member 000 0000
0000 00000000 00.0 Evotec Chief Scientific Officer & Board Member 000 0000
000000 00000000 00.0 Carrick Therapeutics Supervisory Board Member 000 0000
0000 00000000 Evotec Chief Financial Officer & Board Member 000 0000
0000 000-000000000 Evotec Supervisory Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Evotec Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evotec Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Evotec‘s full profile, request access.

Request a free trial

Evotec Investments & Acquisitions (38)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 19-Oct-2020 00000 00000 00 000.00 Drug Discovery 000000 000000000 00
000000000 06-Oct-2020 00000 00000 00 Drug Discovery 0000 00000000 00.0
0000000 0000000000 21-Jul-2020 0000 00000 Drug Discovery 000000 000000000 00
000000 (0000000 00 01-Jul-2020 000000000 00000 00 Buildings and Property 000000 000000000 00
Exscientia 26-May-2020 Later Stage VC 000.00 Other Healthcare Technology Systems 000000 000000000 00
You’re viewing 5 of 38 investments and acquisitions. Get the full list »

Evotec Subsidiaries (3)

Company Name Industry Location Founded
Just Biotherapeutics Biotechnology Seattle, WA 2014
000000 Drug Discovery Princeton, NJ 0000
00000000 Biotechnology Cheshire, United Kingdom 0000
To view Evotec’s complete subsidiaries history, request access »